Trials / Completed
CompletedNCT00171522
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 52 (planned)
- Sponsor
- Novartis · Industry
- Sex
- Female
- Age
- 18 Years – 64 Years
- Healthy volunteers
- —
Summary
To determine whether female patients have a preference for tegaserod of PEG 3350 relative to dosage form, convenience, ease of administration and taste
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tegaserod and Polyethylene Glycol 3350 |
Timeline
- Start date
- 2005-05-01
- Completion
- 2005-09-01
- First posted
- 2005-09-15
- Last updated
- 2016-03-03
Locations
14 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00171522. Inclusion in this directory is not an endorsement.